Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2005
08/25/2005WO2004106493A3 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
08/25/2005WO2004069394A3 Synthetic method for direct arylation of heterocyclic arenes
08/25/2005US20050187390 Bicyclic heteroaryl derivatives
08/25/2005US20050187313 Process for aqueous milling of quinacridone pigments
08/25/2005US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction
08/25/2005US20050187282 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands
08/25/2005US20050187240 Derivatives as antitumor, anticarcinogenic agents and microbiocides; conversion of isoaaptamine which is relatively unstable to its novel and more stable sodium phosphate prodrug, hystatin 1; conversion of aaptamine to numerous compounds including 9-demethyloxyaaptamine and 4-methylaaptamine
08/25/2005US20050187237 Therapeutic compounds and uses thereof
08/25/2005US20050187230 Compounds and compositions as protein kinase inhibitors
08/25/2005US20050187223 Antiinflammatory agents; rheumatic diseases;Paget's disease; leukemia; inflammatory bowel disorders; adult respiratory distress syndrome; antiallergens; Alzheimer's disease;%
08/25/2005US20050187217 Sodium channel modulators; pain relievers; treating epilepsy, neurodegenerative disorders, psychiatric disorders, arrhythmia, movement disorders, autoimmune diseases, and incontinence; fused ring 4-aminopyrimidines e.g. 4-amino-5,6,7,8-tetrahydroquinazolines
08/25/2005US20050187203 combination of a pyrazolo(1,5-a)pyridine compound such as ibudilast with a corticosteroid; treating immunoinflammatory disorders e.g. rheumatoid arthritis, ulcerative colitis
08/25/2005US20050187194 fructose 1,6-bisphosphatase (FBPase) inhibitors for diabetic complications, hyperlipidemia, hypertension, arteriosclerosis, macroangiopathy; 2-amino-5-isobutyl-4-{2-[5-(N,N'-bis((S)-1-ethoxycarbonyl)ethyl)phosphonamido]furanyl}thiazole
08/25/2005US20050187110 Novel herbicides
08/25/2005US20050183635 stability of gamma-quinacridone pigment during milling by addition of 2,9-dichloroquinacridone
08/25/2005DE102004006143A1 Neue Naphthalinderivate und diese Verbindungen enthaltende Färbemittel für Keratinfasern New naphthalene derivatives and compositions containing these compounds colorant for keratin fibers
08/25/2005CA2556084A1 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders
08/25/2005CA2555827A1 Tricyclic imidazopyridines and intermediates for the synthesis thereof
08/25/2005CA2555815A1 Dihydrotetrabenazines and pharmaceutical compositions containing them
08/25/2005CA2555685A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
08/25/2005CA2555287A1 Heterocyclic gaba-a subtype selective receptor modulators
08/25/2005CA2555176A1 Hiv integrase inhibitors
08/25/2005CA2555132A1 Compounds that inhibit hiv particle formation
08/25/2005CA2554465A1 Piperidine derivatives useful as ccr3 antagonists
08/25/2005CA2554302A1 Perylene n-type semiconductors and related devices
08/25/2005CA2549216A1 Sulfone substituted imidazo ring ethers
08/25/2005CA2536622A1 Inhibitors of cellular necrosis
08/24/2005EP1566380A1 Isoquinoline compounds and medicinal use thereof
08/24/2005EP1565467A1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
08/24/2005EP1565466A2 Method of preparing inhibitors of phosphodiesterase-4
08/24/2005EP1565465A1 8-substituted imidazopyridines
08/24/2005EP1565464A1 4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors
08/24/2005EP1565463A1 Imidazo[1,5a]pyridine derivatives and methods for treating aldosterone mediated diseases
08/24/2005EP1565455A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
08/24/2005EP1565452A2 3-substituted-6-aryl pyridines as ligands of c5a receptors
08/24/2005EP1565445A1 Novel process for the preparation of imidazolyl compounds
08/24/2005EP1565187A2 Methods of treating cancer and related methods
08/24/2005EP1409459A4 Ecl labels having improved non-specific binding properties, methods of using and kits containing the same
08/24/2005EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
08/24/2005EP1360185B1 Carboline derivatives
08/24/2005EP1353912B1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
08/24/2005EP1343789B1 Tricyclic derivatives of indole with antiangiogenic activity
08/24/2005EP1335917B1 Condensed pyridoindole derivatives
08/24/2005EP1317413B1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
08/24/2005EP1158980B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1659266A Ligand and complex for catalytically bleaching a substrate
08/24/2005CN1659169A Riboflavin derivative and its preparation method and uses
08/24/2005CN1659167A 1, 6, 9, 14-tetrasubstituted terrylene tetracarboxylic acid diimides
08/24/2005CN1659166A 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
08/24/2005CN1659165A Quinolinone derivatives
08/24/2005CN1659156A Novel guanidinobenzamides
08/24/2005CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
08/24/2005CN1658875A 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists
08/24/2005CN1658874A (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists
08/24/2005CN1658866A Tri-substituted heteroaryls and methods of making and using the same
08/24/2005CN1658847A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
08/24/2005CN1657523A Cyclic compounds
08/24/2005CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor
08/23/2005US6933312 Pyrazole derivatives
08/23/2005US6933306 Anticancer agents; antiinflammatory agents; autoimmune disease
08/23/2005US6933305 Amide compounds and use thereof
08/23/2005US6933304 Antitumor agents, osteoporosis
08/23/2005US6933303 Antidiabetic agents
08/23/2005US6933299 Anilinoquinazolines as protein tyrosine kinase inhibitors
08/23/2005US6933297 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione and the use thereof for the treatment of pain
08/23/2005US6933295 Substituted isoindoles and the use thereof
08/23/2005US6933293 Unit treatment dose and patient package
08/18/2005WO2005075600A1 Organic element for electroluminescent devices
08/18/2005WO2005075482A1 Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
08/18/2005WO2005075481A1 Novel naphthalene derivatives and coloring agents containing these compounds, for keratin fibers
08/18/2005WO2005075480A1 Diaza- or thiazadione derivatives with neuroprotective activity
08/18/2005WO2005075478A1 Kinase inhibitors
08/18/2005WO2005075477A1 Antibacterial compounds
08/18/2005WO2005075476A1 Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof
08/18/2005WO2005075475A1 Naphthylidine derivative having hiv integrase inhibitory activity
08/18/2005WO2005075459A1 Synthesis of cyanoimino-benzoimidazoles
08/18/2005WO2005075451A1 Aminodibenzodioxin derivative and organic electroluminescent device using same
08/18/2005WO2005074940A1 Diazabicyclic aryl derivatives as cholinergic receptor modulators
08/18/2005WO2005074642A2 Chemical compounds
08/18/2005WO2005058890A3 Hydronopol derivatives as agonists on human orl1 receptors
08/18/2005WO2005058888A3 Oxazolidinone-quinolone hybrid antibiotics
08/18/2005WO2005056554A3 Azepinoindole derivatives as pharmaceutical agents
08/18/2005WO2005054236B1 Substituted quinolines for the treatment of cancer
08/18/2005WO2005030794A3 Hemiasterlin derivatives and uses thereof
08/18/2005WO2005021547A3 Heterocyclic cannabinoid cb2 receptor antagonists
08/18/2005WO2004060890A8 2-oxopyridin-3-yl thia (di) azole derivates for use in the treatment of cell proliferation and apoptosis related diseases
08/18/2005US20050182095 Piperdine derivatives useful as CCR3 antagonists
08/18/2005US20050182093 Novel compounds
08/18/2005US20050182087 antidiabetic agents; type 2 diabetes; e.g. 1-Ethyl-6-(1-ethynylcyclohexylamino)-7-methyl-4-oxo-1,4-dihydro-(1,8)naphthyridine-3-carboxylate
08/18/2005US20050182086 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
08/18/2005US20050182085 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
08/18/2005US20050182083 Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof
08/18/2005US20050182082 Modulators of the glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof
08/18/2005US20050182080 Therapeutic compounds
08/18/2005US20050182078 inhibitors of cyclin-dependent kinases 2 and 4 (CDK2 and CDK4); antiproliferative agents; cancer, endometriosis, postsurgical vascular stenosis and restenosis
08/18/2005US20050182068 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
08/18/2005US20050182061 Phthalimide compounds useful as protein kinase inhibitors
08/18/2005US20050182047 Treatment of demyelinating disorders
08/18/2005US20050182046 Alzheimer's disease; 3-(S)-(N'-(3,5-difluorophenylacetyl)-L-alaninyl)amino-1-benzyl- epsilon -caprolactam; 4-(N'-(3,5-Difluorophenylacetyl)-L-alaninyl)amino-1-(pyrid-4-yl)-71,2,3,4-tetrahydroisoquinolin-3-one
1 ... 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 ... 646